NPPA issued the retail price of the Cefpodoxime Proxetil IP Eq. to Cefpodoxime 50 mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 31.25 mg 2. Sterile Water for reconstitution (Pyrogen free) 30ml for M/s Malik Lifesciences Pvt. Ltd. (Manufacturer) & M/s Blue Cross Laboratories Pvt. Ltd. (Marketer)

May 08, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on May 07, 2026, issued the retail price of the Cefpodoxime Proxetil IP Eq. to Cefpodoxime 50 mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 31.25 mg 2. Sterile Water for reconstitution (Pyrogen free) 30ml for M/s Malik Lifesciences Pvt. Ltd. (Manufacturer) & M/s Blue Cross Laboratories Pvt. Ltd. (Marketer).

The following has been stated:

• The retail price for the Each Combipack Contains: 1. Cefpodoxime & Potassium Clavulanate Oral Suspension Each 5 ml of constituted suspension contains: Cefpodoxime Proxetil IP Eq. to Cefpodoxime 50 mg Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 31.25 mg 2. Sterile Water for reconstitution (Pyrogen free) 30ml for M/s Malik Lifesciences Pvt. Ltd. (Manufacturer) & M/s Blue Cross Laboratories Pvt. Ltd. (Marketer) will be Rs. 3.65/-.

• Sum of MAT value considered for price calculation (in Lakhs) - 7,083.06 

• Sum of PTR per unit considered for price calculation - 59.81 

[Notification No. 19(5146)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT